Wenfeng Liu

ORCID: 0009-0008-4428-9324
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Adipose Tissue and Metabolism
  • Cancer therapeutics and mechanisms
  • Bioactive Compounds and Antitumor Agents
  • Food Allergy and Anaphylaxis Research
  • Cancer-related molecular mechanisms research
  • Alzheimer's disease research and treatments
  • Gut microbiota and health
  • Cancer, Hypoxia, and Metabolism
  • Autophagy in Disease and Therapy
  • Allergic Rhinitis and Sensitization
  • Lung Cancer Research Studies
  • Immune cells in cancer
  • Protein Degradation and Inhibitors
  • Contact Dermatitis and Allergies
  • Multiple Myeloma Research and Treatments
  • Tryptophan and brain disorders
  • Neuroinflammation and Neurodegeneration Mechanisms
  • RNA modifications and cancer
  • Cholesterol and Lipid Metabolism
  • Asthma and respiratory diseases
  • Cancer Mechanisms and Therapy
  • Physical Activity and Health
  • Cancer, Lipids, and Metabolism
  • Exercise and Physiological Responses
  • ATP Synthase and ATPases Research

Hunan Normal University
2008-2025

Fudan University
2024-2025

Zhongshan Hospital
2024-2025

Xi'an Jiaotong University
2025

Wuyi University
2016-2024

Sun Yat-sen University
2019-2024

Shanghai Institute of Hematology
2024

Shenzhen University
2024

Shanghai Medical College of Fudan University
2024

Sixth Affiliated Hospital of Sun Yat-sen University
2024

Multilayer ceramic capacitor as a vital core-component for various applications is always in the spotlight. Next-generation electrical and electronic systems elaborate further requirements of multilayer capacitors terms higher energy storage capabilities, better stabilities, environmental-friendly lead-free, etc., where these major obstacles may restrict each other. An effective strategy performance global optimization put up here by constructing local polymorphic polarization configuration...

10.1038/s41467-024-55491-5 article EN cc-by-nc-nd Nature Communications 2025-01-02

Inhibition of the bromodomain transcriptional regulator CBP/P300 is an especially interesting new therapeutic approach in oncology. We recently disclosed vivo chemical tool 1 (GNE-272) for CBP that was moderately potent and selective over BRD4(1). In pursuit a more inhibitor, we used structure-based design. Constraining aniline into tetrahydroquinoline motif maintained potency increased selectivity 2-fold. Structure–activity relationship studies coupled with further design targeting LPF...

10.1021/acs.jmedchem.7b00796 article EN Journal of Medicinal Chemistry 2017-09-11

Neuroinflammation occurs throughout the pathogenesis of Alzheimer's disease (AD). Here, we investigated effects treadmill exercise on neuroinflammation in APP/PS1 transgenic AD mice and potential involvement microbe-gut-brain axis (MGB) mechanisms based growing evidence that AD's is correlated with a deterioration function gut microbiota. were subjected to 12 weeks exercise, followed by spatial memory tests. After behavioral study, amyloid (Aβ) pathology, microbes metabolites, bacterial...

10.3390/nu14194134 article EN Nutrients 2022-10-05

Background Hepatocellular carcinoma (HCC) is an exceptionally immunosuppressive malignancy characterized by limited treatment options and a dismal prognosis. Macrophages constitute the primary heterogeneous immune cell population within HCC microenvironment. Our objective to identify distinct subsets of macrophages implicated in progression their resistance immunotherapy. Methods Intratumoral macrophage-specific marker genes were identified via single-cell RNA sequencing analyses. The...

10.1136/jitc-2023-008094 article EN cc-by-nc Journal for ImmunoTherapy of Cancer 2024-01-01

The single bromodomain of the closely related transcriptional regulators CBP/EP300 is a target much recent interest in cancer and immune system regulation. A co-crystal structure ligand-efficient screening hit CBP guided initial design targeting LPF shelf, ZA loop, acetylated lysine binding regions. Structure-activity relationship studies allowed us to identify more potent analogue. Optimization permeability microsomal stability subsequent improvement mouse hepatocyte afforded 59 (GNE-272,...

10.1021/acs.jmedchem.6b01022 article EN Journal of Medicinal Chemistry 2016-09-22

A growing body of clinical data has shown that patients with Alzheimer’s disease (AD) have symptoms such as liver dysfunction and microbial–gut–brain axis in addition to brain pathology, presenting a systemic multisystemic pathogenesis. Considering the benefits exercise, here, we first observed effects long-term treadmill exercise on injuries APP/PS1 transgenic AD mice explored potential mechanisms gut–liver–brain axis’s role mediating exercise’s ability reduce bacterial...

10.18632/aging.205432 article EN cc-by Aging 2024-01-29

A series of trisubstituted hydroxylactams was identified as potent enzymatic and cellular inhibitors human lactate dehydrogenase A. Utilizing structure-based design physical property optimization, multiple were discovered with <10 μM IC50 in a MiaPaca2 cell line. Optimization the led to 29, active molecule (MiaPaca2 = 0.67 μM) that also possessed good exposure when dosed orally mice.

10.1021/acsmedchemlett.6b00190 article EN ACS Medicinal Chemistry Letters 2016-08-27

The efficacy of immunotherapy targeting the PD-1/PD-L1 pathway in hepatocellular carcinoma (HCC) is limited. NOD-like receptors (NLRs) comprise a highly evolutionarily conserved family cytosolic bacterial sensors, yet their impact on antitumor immunity against HCC remains unclear. In this study, we uncovered that NOD1, well-studied member NLR family, exhibits predominant expression tumor-associated macrophages (TAMs) and correlates positively with improved prognosis responses to anti–PD-1...

10.1126/sciadv.adp8266 article EN cc-by-nc Science Advances 2024-10-02

Abstract Given that glioma stem cells (GSCs) play a critical role in the initiation and chemoresistance glioblastoma multiforme (GBM), targeting GSCs is an attractive strategy to treat GBM. Utilizing anti-cancer compound library, we identified R406, active metabolite of FDA-approved Syk inhibitor for immune thrombocytopenia (ITP), with remarkable cytotoxicity against but not normal neural cells. R406 significantly inhibited neurosphere formation triggered apoptosis GSCs. induced metabolic...

10.1038/s41419-019-1587-0 article EN cc-by Cell Death and Disease 2019-05-01

Abnormalities in autophagy are associated with Alzheimer's disease (AD)-like lesions. Studies have shown that exercise can significantly improve AD abnormalities, but the mechanism underlying this phenomenon remains unclear. APN not only has an important regulatory effect on also is affected by exercise. Therefore, study aims to reveal pathway which regulates abnormal using APN-AdipoR1 signaling as entry point. The results of showed APP/PS1 double transgenic model mice (24 weeks) decreased...

10.3390/ijms23179921 article EN International Journal of Molecular Sciences 2022-08-31

10.1016/j.jmps.2024.106019 article EN cc-by Journal of the Mechanics and Physics of Solids 2025-01-01

<title>Abstract</title> This study explored the potential of a low-protein diet (LPD) to modulate gut microbiota, focusing on pancreatic ductal adenocarcinoma (PDAC) progression and response immunotherapy. A 25% reduction in dietary protein intake attenuated PDAC development, drove immune activation tumor microenvironment (TME) boosted immunostimulatory tumor-associated macrophages (TAMs) phenotype. We found depletion microbiota compromised anti-tumor effect LPD. Specifically, significant...

10.21203/rs.3.rs-5804694/v1 preprint EN 2025-01-29

Hepatocellular carcinoma tumor-repopulating cells (HCC-TRCs) drive disease progression, yet their purine metabolism mechanisms remain poorly understood. This study revealed that the stemness index, strongly linked to poor HCC prognosis, exhibited a robust positive correlation with through single-sample gene set enrichment analysis (ssGSEA). Integrated drug screening across CTRP, GDSC, and PRISM databases identified alisertib, an Aurora kinase A inhibitor, as potent agent targeting stemness....

10.1016/j.jbc.2025.108558 article EN cc-by Journal of Biological Chemistry 2025-04-01

<title>Abstract</title> Typical pathological features of Alzheimer's disease include disturbances in cholesterol metabolism and defects lysosomal function the brain. With age progression, patients with have decreased synthesis brain abnormal accumulation neurons, accompanied by elevated 27-hydroxycholesterol concentrations. High-cholesterol diets are more common patients, which may promote further exacerbate disturbance This leads to entry into through blood-brain barrier, where it disrupts...

10.21203/rs.3.rs-6361968/v1 preprint EN Research Square (Research Square) 2025-05-09

Using structure- and ligand-based design principles, a novel series of piperidyl chromane arylsulfonamide Nav1.7 inhibitors was discovered. Early optimization focused on improvement potency through refinement the low energy ligand conformation mitigation high in vivo clearance. An vitro hepatotoxicity hazard identified resolved lipophilicity lipophilic efficiency to arrive at GNE-616 (24), highly potent, metabolically stable, subtype selective inhibitor Nav1.7. Compound 24 showed robust...

10.1021/acs.jmedchem.9b00141 article EN Journal of Medicinal Chemistry 2019-04-03

Abstract Homocamptothecin (hCPT) is a camptothecin (CPT) homologue with the insertion of methylene (CH 2 ) spacer between alcohol moiety and carbonyl group classical six‐membered α‐hydroxylactone ring. This modification provides higher lactone stability did not impair its activity against topoisomerase I (Topo I), but rather appears to improve it compared CPT. In an attempt antitumor homocamptothecins, series novel hCPT derivatives conjugating dihydropyrimidine (DHPM) was designed...

10.1002/ardp.201000402 article EN Archiv der Pharmazie 2011-09-29
Coming Soon ...